Correction

Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection

N Engl J Med 2000; 343:672August 31, 2000

Article

Prophylaxis against Opportunistic Infections in Patients with Human Immunodeficiency Virus Infection (Review Article, N Engl J Med 2000:342;1416 - 1429) . On page 1421, beginning on the first line of the right-hand column, the dose of the double-strength tablet should have read, “160 mg of trimethoprim plus 800 mg of sulfamethoxazole,” not “80 mg of trimethoprim plus 400 mg of sulfamethoxazole,” as printed, and the dose of the single-strength tablet should have read, “80 mg of trimethoprim plus 400 mg of sulfamethoxazole,” not “40 mg of trimethoprim plus 200 mg of sulfamethoxazole,” as printed. Also, in Table 2, next to the entry “Isoniazid-resistant source case (if known),” the first-choice regimen should have read, “Rifampin, 600 mg orally per day, plus pyrazinamide, 20 mg/kg orally per day, for 2 mo,” not “pyrazinamide, 200 mg/kg,” as printed. We regret the error.